Study suggests obesity medication could reduce the risk of type 2 diabetes

New York, Sep 12 : The risk of type 2 diabetes is reduced by more than half by regular injections of the latest obesity drug semaglutide, which was just accepted in the US and has been formally approved in England according to an upcoming study.